Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

HHS adds eight substances to 12th Report on Carcinogens

The U.S. Department of Health and Human Services added eight substances to its Report on Carcinogens, a science-based document that identifies chemicals and biological agents that may put people at increased risk for cancer.

13 Jun 2011

Boys, girls with ADHD may differ from each other in their vulnerability to substance use problems

According to a recent Finnish study, boys and girls with attention deficit hyperactivity disorder (ADHD) may differ from each other in their vulnerability to substance use problems. Inattentiveness and hyperactivity may be more predictive of alcohol use disorders and maladaptive patterns of alcohol and illicit drug use among girls than boys.

10 Jun 2011

Study finds brain differences in preschool children with symptoms of ADHD

In a study published today in the Clinical Neuropsychologist, researchers from the Kennedy Krieger Institute found differences in the brain development of preschool children with symptoms of Attention-deficit/Hyperactivity Disorder (ADHD).

10 Jun 2011

Children who experience trauma more likely to have behavior and learning problems

New research has shown that children's risk for learning and behavior problems and obesity rises in correlation to their level of trauma exposure, says the psychiatrist at the Stanford University School of Medicine and Lucile Packard Children's Hospital who oversaw the study.

9 Jun 2011

Childhood trauma linked to higher rates of mental health problems and obesity, says Stanford/Packard psychiatrist

New research has shown that children’s risk for learning and behavior problems and obesity rises in correlation to their level of trauma exposure, says the psychiatrist at the Stanford University School of Medicine and Lucile Packard Children’s Hospital who oversaw the study. The findings could encourage physicians to consider diagnosing post-traumatic stress disorder rather than attention deficit/hyperactivity disorder, which has similar symptoms to PTSD but very different treatment.

8 Jun 2011

Multiple exposures to anesthesia may increase risk of ADHD, learning disabilities in young children

Infants and very young children who are exposed to anesthesia may experience higher rates of learning disabilities and cognitive difficulties than children who are not exposed to anesthesia, according to research and emerging data presented during the SmartTots: Pediatric Anesthesia Neurotoxicity panel at the International Anesthesia Research Society annual meeting in Vancouver, B.C.

30 May 2011

Adjusting life goals can help family caregivers prevent depressive symptoms: Study

Caring for a family member with a mental illness can be a taxing experience marked by personal sacrifices and psychological problems.

21 May 2011

Study finds no potential cardiovascular risks of ADHD medications in children, adolescents

Despite recent concerns that medications for attention deficit hyperactivity disorder could increase the risk of cardiovascular events in children and adolescents, an observational study conducted by researchers at the University of Pennsylvania School of Medicine and HealthCore Inc. finds they are no more likely to die from a severe cardiovascular event than those who do not take the drugs.

16 May 2011

New autism research findings presented at 10th annual IMFAR

Much about autism is unknown, but researchers from the University of Rochester Medical Center (URMC) are working to learn more about the neurodevelopmental disorder and its most effective treatments. A team of researchers from URMC joins researchers from across the world in San Diego this week for the 10th annual International Meeting for Autism Research (IMFAR).

16 May 2011

VAYA Pharma's Vayarin now available in South, North Carolina and Texas for children with ADHD

\VAYA Pharma announced the availability of Vayarin in pharmacies throughout North Carolina, South Carolina and Texas for children suffering with Attention-Deficit / Hyperactivity Disorder (ADHD).

16 May 2011

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) today announced results from a Phase 2 clinical trial of OPC-34712, a novel D2 dopamine partial agonist investigational product.

16 May 2011

Longer looks: Conservatives vs. liberals on Medicare - who's winning?

What you really need to know is that Tuesday was a great day in court for supporters of the Care Act and a very tough one for its opponents. That dynamic could easily change within the next six weeks or so when the 11th Circuit, the 6th Circuit, and the 3rd Circuit also hold their oral arguments on Care Act appeals. Either way, we are one step closer to the end of all of this, and you can bet that the justices were paying attention up the road a bit from Richmond.

13 May 2011

ADHD in children linked to stress and depression during pregnancy

According to the latest research women who are depressed or severely stressed during their pregnancy have a greater chance of having children with attention deficit hyperactivity disorder. It has been known till now that ADHD is largely inheritable but now it comes out that antenatal anxiety could contribute to 15 per cent of cases of the behavioural condition in children.

8 May 2011

Alza files patent infringement suit against Impax in connection with Concerta

Impax Laboratories, Inc. today confirms that Alza Corporation has filed suit for patent infringement against Impax in the United States District Court for the District of Delaware in connection with Concerta extended-release 18, 27 and 36 mg tablets.

7 May 2011

Study explores impact of environmental toxins on health care costs and childhood morbidity

In three new studies published in the May issue of the journal Health Affairs, Mount Sinai School of Medicine researchers reveal the staggering economic impact of toxic chemicals and air pollutants in the environment, and propose new legislation to mandate testing of new chemicals and also those already on the market.

5 May 2011

Marianjoy Medical Library launches new website on developmental problems, chronic conditions

InformationConnections.org, the informative website for parents of children with developmental disabilities and chronic diseases, was recently launched by the Marianjoy Medical Library. The National Network of Libraries of Medicine, Greater Midwest Region, provided a grant to create and manage the website.

5 May 2011

Watson introduces generic version of Concerta

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., has launched an authorized generic version of Concerta as part of an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc.

2 May 2011

Brain function variations may increase person's risk of drug abuse

One can look at drug addiction as a moral issue, a social ill, or a criminal problem. But Lynn Oswald's experience studying the neuroscience of addiction tells her that it is something else entirely: a disease of the brain.

30 Apr 2011

Positive results from Shire's Vyvanse clinical trial in schizophrenia

Shire plc, the global specialty biopharmaceutical company, today announced positive results from a signal-finding study of Vyvanse(R) Capsules assessing its effect in a prospective examination of adults with negative symptom predominant schizophrenia.

28 Apr 2011

USPTO grants Cortex patent for CX1739 AMPAKINE molecule

Cortex Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent that protects its lead AMPAKINE® molecule, CX1739.

26 Apr 2011

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

HHS adds eight substances to 12th Report on Carcinogens

Boys, girls with ADHD may differ from each other in their vulnerability to substance use problems

Study finds brain differences in preschool children with symptoms of ADHD

Children who experience trauma more likely to have behavior and learning problems

Childhood trauma linked to higher rates of mental health problems and obesity, says Stanford/Packard psychiatrist

Multiple exposures to anesthesia may increase risk of ADHD, learning disabilities in young children

Adjusting life goals can help family caregivers prevent depressive symptoms: Study

Study finds no potential cardiovascular risks of ADHD medications in children, adolescents

New autism research findings presented at 10th annual IMFAR

VAYA Pharma's Vayarin now available in South, North Carolina and Texas for children with ADHD

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Longer looks: Conservatives vs. liberals on Medicare - who's winning?

ADHD in children linked to stress and depression during pregnancy

Alza files patent infringement suit against Impax in connection with Concerta

Study explores impact of environmental toxins on health care costs and childhood morbidity

Marianjoy Medical Library launches new website on developmental problems, chronic conditions

Watson introduces generic version of Concerta

Brain function variations may increase person's risk of drug abuse

Positive results from Shire's Vyvanse clinical trial in schizophrenia

USPTO grants Cortex patent for CX1739 AMPAKINE molecule

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in